Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 162

1.

Impact of left ventricular function on health-related quality of life in coronary artery disease patients.

Staniūtė M, Vaškelytė J, Rumbinaitė E, Kaminskaitė B, Samsanavičienė S, Plungienė S, Brožaitienė J, Bunevičius R.

Medicina (Kaunas). 2015;51(4):233-9. doi: 10.1016/j.medici.2015.07.005. Epub 2015 Aug 1.

2.

[Dyspnea in left-sided heart disease].

Simonis G, Stumpf J, Dörr R, Kadalie CT, Spitzer SG.

Internist (Berl). 2015 Aug;56(8):890-9. doi: 10.1007/s00108-015-3688-x. Review. German.

PMID:
26122496
3.

Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial.

Badar AA, Perez-Moreno AC, Hawkins NM, Jhund PS, Brunton AP, Anand IS, McKelvie RS, Komajda M, Zile MR, Carson PE, Gardner RS, Petrie MC, McMurray JJ.

Circ Heart Fail. 2015 Jul;8(4):717-24. doi: 10.1161/CIRCHEARTFAILURE.114.002024. Epub 2015 Jun 11.

PMID:
26067854
4.

Use of Loop Diuretics is Associated with Increased Mortality in Patients with Suspected Coronary Artery Disease, but without Systolic Heart Failure or Renal Impairment: An Observational Study Using Propensity Score Matching.

Schartum-Hansen H, Løland KH, Svingen GF, Seifert R, Pedersen ER, Nordrehaug JE, Bleie Ø, Ebbing M, Berge C, Nilsen DW, Nygård O.

PLoS One. 2015 Jun 1;10(6):e0124611. doi: 10.1371/journal.pone.0124611. eCollection 2015.

5.
6.

Enhanced external counterpulsation reduces indices of central blood pressure and myocardial oxygen demand in patients with left ventricular dysfunction.

Beck DT, Casey DP, Martin JS, Sardina PD, Braith RW.

Clin Exp Pharmacol Physiol. 2015 Apr;42(4):315-20. doi: 10.1111/1440-1681.12367.

7.

Low IL-10/TNFα ratio in patients with coronary artery disease and reduced left ventricular ejection fraction with a poor prognosis after 10 years.

Dopheide JF, Knopf P, Zeller GC, Vosseler M, Abegunewardene N, Münzel T, Espinola-Klein C.

Inflammation. 2015 Apr;38(2):911-22. doi: 10.1007/s10753-014-0053-5.

PMID:
25384561
8.

Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial.

Mark DB, Knight JD, Velazquez EJ, Wasilewski J, Howlett JG, Smith PK, Spertus JA, Rajda M, Yadav R, Hamman BL, Malinowski M, Naik A, Rankin G, Harding TM, Drew LA, Desvigne-Nickens P, Anstrom KJ.

Ann Intern Med. 2014 Sep 16;161(6):392-9. doi: 10.7326/M13-1380.

9.

[Emergency coronary artery bypass grafting for acute coronary syndrome: mid-term follow-up results].

Xiao C, Wang R, Li B, Wu Y, Wang G, Ren C, Ye W, Sheng W, Li J, Wang J, Chen T, Zhou Q, Zhang T, Ma L, Gao C.

Nan Fang Yi Ke Da Xue Xue Bao. 2014 May;34(5):679-82. Chinese.

11.

What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?

Campbell RT, Jhund PS, Castagno D, Hawkins NM, Petrie MC, McMurray JJ.

J Am Coll Cardiol. 2012 Dec 11;60(23):2349-56. doi: 10.1016/j.jacc.2012.04.064. Epub 2012 Nov 7. Review.

12.

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.

Lam CS, Carson PE, Anand IS, Rector TS, Kuskowski M, Komajda M, McKelvie RS, McMurray JJ, Zile MR, Massie BM, Kitzman DW.

Circ Heart Fail. 2012 Sep 1;5(5):571-8. Epub 2012 Aug 10.

13.

Interval training confers greater gains than continuous training in people with heart failure.

Maiorana A.

J Physiother. 2012;58(3):199. doi: 10.1016/S1836-9553(12)70113-3.

14.

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.

Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

JAMA. 2012 Apr 25;307(16):1717-26. doi: 10.1001/jama.2012.418. Epub 2012 Mar 24. Erratum in: JAMA. 2015 Jul 7;314(1):86.

15.
16.

Evaluation of aggressive heart rate reduction in patients with stable angina.

Azeem HA, Khalek el SA, Akabawy HE.

J Saudi Heart Assoc. 2011 Apr;23(2):67-73. doi: 10.1016/j.jsha.2010.12.001. Epub 2011 Jan 1.

17.

Subclinical left ventricular echocardiographic abnormalities 1 year after kidney transplantation are associated with graft function and future cardiovascular events.

Arnol M, Knap B, Oblak M, Buturović-Ponikvar J, Bren AF, Kandus A.

Transplant Proc. 2010 Dec;42(10):4064-8. doi: 10.1016/j.transproceed.2010.09.044.

PMID:
21168628
18.

The Heart Failure Revascularisation Trial (HEART).

Cleland JG, Calvert M, Freemantle N, Arrow Y, Ball SG, Bonser RS, Chattopadhyay S, Norell MS, Pennell DJ, Senior R.

Eur J Heart Fail. 2011 Feb;13(2):227-33. doi: 10.1093/eurjhf/hfq230. Epub 2010 Dec 13.

19.

Distribution of left ventricular ejection fraction in angina patients with severe coronary artery disease not amenable to revascularization.

Gupta S, Pressman GS, Morris DL, Figueredo VM.

Coron Artery Dis. 2010 Aug;21(5):278-80. doi: 10.1097/MCA.0b013e32833bdf53.

PMID:
20531008
20.

Exercise-induced changes of B-type natriuretic peptide uncover the unknown coronary artery disease in patients with chest pain and normal left ventricular systolic function.

Paraskevaidis IA, Tsougos E, Varounis C, Dagres N, Karatzas D, Parissis J, Kremastinos DT.

Eur J Cardiovasc Prev Rehabil. 2011 Feb;18(1):72-8. doi: 10.1097/HJR.0b013e32833a4529.

PMID:
20485180
Items per page

Supplemental Content

Loading ...
Write to the Help Desk